<Disease><Name>MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A (MOCODA)</Name><Synonym>SULFITE OXIDASE, XANTHINE DEHYDROGENASE, AND ALDEHYDE OXIDASE, COMBINED DEFICIENCY OF</Synonym><OMIM><Number>252150</Number><URL>http://omim.org/entry/252150</URL></OMIM><Orphanet><Number>833</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=833</URL></Orphanet><Protein><Number>Molybdenum cofactor biosynthesis protein 1</Number><URL>http://www.uniprot.org/uniprot/Q9NZB8</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>6p21.2</Gene><ICD>E72.1</ICD><Summary>rare ;autosomal recessive ;mutation in the MOCS1 gene</Summary><Symptoms><symtomp><id>3928</id><symptom>altered consciousness, consciousness disturbance</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2088</id><symptom>Amino acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2130</id><symptom>bleeding tendencies, hemorrhages / bleeding tendencies, hemorrhage</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3677</id><symptom>cardiomyopathy, hypertrophic</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1737</id><symptom>dislocated lens (ectopia lentis) / ectropion</symptom><category>EYES</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2430</id><symptom>enophthalmus</symptom><category>EYES</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>4106</id><symptom>live threatening illness</symptom><category /></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2298</id><symptom>opisthotonus</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4056</id><symptom>seizures, tonic clonic</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1642</id><name>Cystine</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>24.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1693</id><name>Taurine</name><specimen>urine</specimen><value>increased</value><min>13.00</min><max>251.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1761</id><name>Cystine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>75.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1769</id><name>Homocysteine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>170.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1785</id><name>Taurine</name><specimen>urine</specimen><value>increased</value><min>250.00</min><max>910.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1927</id><name>Taurine</name><specimen>plasma</specimen><value>increased</value><min>2.00</min><max>90.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1974</id><name>Taurine</name><specimen>plasma</specimen><value>increased</value><min>35.00</min><max>245.00</max><unit>&#956;mol/l</unit><age>all</age><method>HPLC</method><comment /></metabolite><metabolite><id>2093</id><name>alpha-Aminoadipic semialdehyde</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>1.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>2094</id><name>alpha-Aminoadipic semialdehyde</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.50</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>151</id><name>Cystine</name><specimen>urine</specimen><value>increased</value><min>24.00</min><max>78.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1496</id><name>Cystine</name><specimen>plasma</specimen><value>decreased</value><min>5.00</min><max>45.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>509</id><name>Cystine</name><specimen>urine</specimen><value>increased</value><min>12.00</min><max>48.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1495</id><name>Cystine</name><specimen>plasma</specimen><value>decreased</value><min>16.00</min><max>98.00</max><unit>&#956;mol/l</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>867</id><name>Cystine</name><specimen>urine</specimen><value>increased</value><min>8.00</min><max>30.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>150</id><name>Cystine</name><specimen>plasma</specimen><value>decreased</value><min>17.00</min><max>98.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>729</id><name>Cystine</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>0.20</max><unit>nmol/mg protein</unit><age>child</age><method /><comment /></metabolite><metabolite><id>822</id><name>Cystine</name><specimen>leucocytes</specimen><value>decreased</value><min>    </min><max>0.20</max><unit>nmol/mg protein</unit><age>child</age><method /><comment /></metabolite><metabolite><id>461</id><name>Homocysteine</name><specimen>urine</specimen><value>decreased</value><min>4.70</min><max>10.30</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1528</id><name>Homocysteine</name><specimen>urine</specimen><value>decreased</value><min>0.20</min><max>3.70</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>186</id><name>Homocysteine</name><specimen>serum</specimen><value>decreased</value><min>4.80</min><max>7.40</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1391</id><name>Homocysteine</name><specimen>serum</specimen><value>decreased</value><min>4.90</min><max>11.60</max><unit>&#181;mol/l</unit><age>adult, female</age><method /><comment /></metabolite><metabolite><id>1392</id><name>Homocysteine</name><specimen>serum</specimen><value>decreased</value><min>5.90</min><max>15.30</max><unit>&#181;mol/l</unit><age>adult, male</age><method /><comment /></metabolite><metabolite><id>1393</id><name>Homocysteine</name><specimen>serum</specimen><value>decreased</value><min>4.30</min><max>9.90</max><unit>&#181;mol/l</unit><age>adolescent, male</age><method /><comment /></metabolite><metabolite><id>1394</id><name>Homocysteine</name><specimen>serum</specimen><value>decreased</value><min>3.30</min><max>7.20</max><unit>&#181;mol/l</unit><age>adolescent, female</age><method /><comment /></metabolite><metabolite><id>1395</id><name>Homocysteine</name><specimen>serum</specimen><value>decreased</value><min>3.50</min><max>4.10</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>1536</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>88.10</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1537</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.80</min><max>24.10</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1068</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>71.90</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1067</id><name>Hypoxanthine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>10.00</max><unit>&#956;mol/l</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1996</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>71.90</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>1902</id><name>Cystine</name><specimen>urine</specimen><value>increased</value><min>7.00</min><max>23.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1903</id><name>Cystine</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>34.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>193</id><name>S-Sulfocysteine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>18.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>1538</id><name>S-Sulfocysteine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>25.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1551</id><name>S-Sulfocysteine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>192</id><name>S-Sulfocysteine</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>504</id><name>Sulfite</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>child</age><method /><comment /></metabolite><metabolite><id>125</id><name>Taurine</name><specimen>urine</specimen><value>increased</value><min>8.00</min><max>226.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>852</id><name>Taurine</name><specimen>urine</specimen><value>increased</value><min>37.00</min><max>162.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1415</id><name>Taurine</name><specimen>urine</specimen><value>increased</value><min>420.00</min><max>939.00</max><unit>mmol/mol creatinine</unit><age>newborn 1-7d</age><method /><comment /></metabolite><metabolite><id>124</id><name>Taurine</name><specimen>plasma</specimen><value>increased</value><min>20.00</min><max>120.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>451</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>527.00</min><max>790.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1535</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>222.00</min><max>287.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>776</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>820.00</min><max>1026.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>417</id><name>Uric acid</name><specimen>serum</specimen><value>decreased</value><min>120.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1555</id><name>Xanthine</name><specimen>urine</specimen><value>increased</value><min>20.00</min><max>70.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>5991</id><title>A mild case of molybdenum cofactor deficiency defines an alternative route of MOCS1 protein maturation</title><author>Mayr SJ,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>41</volume><number>2</number><pages>187-196</pages><co_aut>et al.</co_aut></literature><literature><id>4001</id><title>Kardiomyopathie - ein  Symptom des Molybd&#228;n-Co-Faktor-Mangels?</title><author>Marten LM,</author><journal>31. Jahrestagung APS Fulda 2017</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5404</id><title>Critical appraisal of genotype assessment in molybdenum cofactor deficiency</title><author>Hinderhofer K,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3569</id><title>[Sulfite oxidase activity deficiency caused by cofactor molybdenum deficiency: A case of early severe encephalopathy]</title><author>Durousset C,</author><journal>Arch Pediatr</journal><year>2016</year><book /><volume>23</volume><number>3</number><pages>292-296</pages><co_aut>et al.</co_aut></literature><literature><id>3575</id><title>Molybdenum cofactor deficiency</title><author>Atwal PS,</author><journal>Mol Genet Metab</journal><year>2016</year><book /><volume>117</volume><number>1</number><pages>1-4</pages><co_aut>Scaglia F</co_aut></literature><literature><id>4000</id><title>Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients</title><author>Zaki MS,</author><journal>Eur J Paediatr Neurol</journal><year>2016</year><book /><volume>20</volume><number>5</number><pages>714-722</pages><co_aut>et al.</co_aut></literature><literature><id>3573</id><title>Isolated sulfite oxidase deficiency</title><author>Relinque B,</author><journal>J Neonatal Perinatal Med</journal><year>2015</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3576</id><title>Treatments for rare diseases: molybdenum cofactor deficiency</title><author>Wilcken B</author><journal>Lancet</journal><year>2015</year><book /><volume>386</volume><number>10007</number><pages>1924-1925</pages><co_aut /></literature><literature><id>3572</id><title>Infantile spasms and hyperekplexia associated with isolated sulfite oxidase deficiency</title><author>Holder JL Jr,</author><journal>JAMA Neurol</journal><year>2014</year><book /><volume>71</volume><number>6</number><pages>782-784</pages><co_aut>et al.</co_aut></literature><literature><id>3574</id><title>Molybdenum cofactor deficiency: metabolic link between taurine and S-sulfocysteine</title><author>Belaidi AA,</author><journal>Adv Exp Med Biol</journal><year>2013</year><book /><volume>776</volume><number>0</number><pages>13-19</pages><co_aut>Schwarz G</co_aut></literature><literature><id>5944</id><title>Molybdenum cofactor deficiency: review of 12 cases (MoCD and review)</title><author>Bayram E,</author><journal>Eur J Paediatr Neurol</journal><year>2013</year><book /><volume>17</volume><number>1</number><pages>1-6</pages><co_aut>et al.</co_aut></literature><literature><id>3570</id><title>Molybdenum cofactor deficiency: Mutations in GPHN, MOCS1, and MOCS2</title><author>Reiss J,</author><journal>Hum Mutat</journal><year>2011</year><book /><volume>32</volume><number>1</number><pages>10-18</pages><co_aut>Hahnewald R</co_aut></literature><literature><id>2272</id><title>Structural insights into sulfite oxidase deficiency</title><author>Karakas E</author><journal>J Biol Chem</journal><year>2005</year><book /><volume>280</volume><number>39</number><pages>33506-15</pages><co_aut>et al.</co_aut></literature><literature><id>2273</id><title>Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2 and in vitro characterization of a MOCS2 mutation that abo</title><author>Leimkuhler S</author><journal>Hum Genet</journal><year>2005</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2274</id><title>Molybdenum cofactor deficiency presenting with severe metabolic acidosis and intracranial hemorrhage</title><author>Teksam O</author><journal>J Child Neurol</journal><year>2005</year><book /><volume>20</volume><number>2</number><pages>155-157</pages><co_aut>Yurdakok M, Coskun T</co_aut></literature><literature><id>2275</id><title>Determination of urinary S-sulphocysteine, xanthine and hypoxanthine by liquid chromatography-electrospray tandem mass spectrom</title><author>Rashed MS</author><journal>Biomed Chromatogr</journal><year>2005</year><book /><volume>19</volume><number>3</number><pages>223-230</pages><co_aut>et al.</co_aut></literature><literature><id>3571</id><title>Molybdenum cofactor deficiency presenting as neonatal hyperekplexia: a clinical, biochemical and genetic study</title><author>Macaya A,</author><journal>Neuropediatrics</journal><year>2005</year><book /><volume>36</volume><number>6</number><pages>389-394</pages><co_aut>et al.</co_aut></literature><literature><id>5203</id><title>Molybdenum cofactor deficiency associated with Dandy-Walker complex</title><author>Arslanoglu S,</author><journal>Brain Dev</journal><year>2001</year><book /><volume>23</volume><number>8</number><pages>815-818</pages><co_aut>et al.</co_aut></literature><literature><id>120</id><title>Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency</title><author>Johnson JL</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2271-2283</pages><co_aut>Wadman SK</co_aut></literature><literature><id>609</id><title>Ophthalmic abnormalities in molybdenum cofactor deficiency and isolated sulfite oxidase deficiency</title><author>Lueder GT</author><journal>J Pediatr Ophthalmol Strabismus</journal><year>1995</year><book /><volume>32</volume><number>0</number><pages>334-337</pages><co_aut>Steiner RD</co_aut></literature><literature><id>17</id><title>The Detection of Molybdenum Cofactor Deficiency: Clinical Symptomatology and Urinary Matabolite Profile</title><author>Gennip AH</author><journal>J Inherit Metab Dis</journal><year>1994</year><book /><volume>17</volume><number>0</number><pages>142-145</pages><co_aut>Abeling NGGM, Stromer AEM, Overmars H, Bakker HD</co_aut></literature></Literatures></Disease>